...
首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Detection of a Shiga toxin- and extended-spectrum-β-lactamase-producing Escherichia coli o157: H7 human clinical isolate
【24h】

Detection of a Shiga toxin- and extended-spectrum-β-lactamase-producing Escherichia coli o157: H7 human clinical isolate

机译:产志贺毒素和广谱β-内酰胺酶的大肠杆菌o157:H7人类临床分离株的检测

获取原文
获取原文并翻译 | 示例
           

摘要

Sir, Shiga toxin-producing Escherichia coli (STEC) is recognized as an important human pathogen that continues to be one of the major causes of food- and waterborne outbreaks. Human infection with STEC is potentially fatal and may be associated with a wide range of symptoms, from uncomplicated diarrhoea to haemorrhagic colitis and haemolytic uraemic syndrome. E. coli isolates resistant to oxyimino cephalosporins due to the production of extended-spectrum beta-lactamases (ESBLs) have emerged worldwide and a number of different ESBL genes such as bla_(SHV),bla_(TEM) and bla_(CTX-M) have been identified from infections in humans as well as in animals.2 Until recently there have only been a few reports of ESBL-producing STEC strains isolated from humans or animals, including the outbreak in May and June 2011 in which an ESBL-producing enteroaggregative E. coli (EAEC) STEC O104:H4 infected 3793 patients in Germany
机译:主席先生,产生志贺毒素的大肠杆菌(STEC)被认为是一种重要的人类病原体,仍然是导致食物和水传播疾病的主要原因之一。人类感染STEC可能致命,并可能伴随多种症状,从简单的腹泻到出血性结肠炎和溶血性尿毒症。由于产生了广谱β-内酰胺酶(ESBLs)而产生的对氧亚氨基头孢菌素具有抗性的大肠杆菌分离株已在世界范围内出现,并且许多不同的ESBL基因,例如bla_(SHV),bla_(TEM)和bla_(CTX-M)从人类和动物的感染中均已鉴定出。2直到最近,仅从人类或动物身上分离出产生ESBL的STEC菌株的报道很少,包括2011年5月和2011年6月的暴发,其中产生了ESBL的肠聚集菌德国感染E. coli(EAEC)STEC O104:H4的3793名患者

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号